The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3194388 64 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
The corona-virus disease 2019 pandemic compromised routine care for
hypertension: a survey conducted among excellence centers of the
European Society of Hypertension
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Background: The Covid-19 pandemic caused a shutdown of healthcare
systems in many countries. We explored the impact on hypertension care
in the Excellence Center (EC) network of the European Society of
Hypertension. Methods: We conducted a 17-question electronic survey
among ECs. Results: Overall, 52 ECs from 20 European and three
non-European countries participated, providing hypertension service for
a median of 1500 hypertensive patients per center per year. Eighty-five
percent of the ECs reported a shutdown lasting for 9 weeks (range 0-16).
The number of patients treated per week decreased by 90%: from a median
of 50 (range 10-400) before the pandemic to a median of 5.0 (range
0-150) during the pandemic (P < 0.0001). 60% of patients (range
0-100%) declared limited access to medical consultations. The majority
of ECs (57%) could not provide 24-h ambulatory BP monitoring, whereas a
median of 63% (range 0-100%) of the patients were regularly performing
home BP monitoring. In the majority (75%) of the ECs, hypertension
service returned to normal after the first wave of the pandemic. In 66%
of the ECs, the physicians received many questions regarding the use of
renin-angiotensin system (RAS) blockers. Stopping RAS-blocker therapy
(in a few patients) either by patients or physicians was reported in 27
and 36.5% of the ECs. Conclusion: Patient care in hypertension ECs was
compromised during the Covid-19-related shutdown. These data highlight
the necessity to develop new strategies for hypertension care including
virtual clinics to maintain services during challenging times.
Έτος δημοσίευσης:
2021
Συγγραφείς:
Weber, Thomas
Januszewicz, Andrzej
Rosei, Enrico Agabiti and
Tsioufis, Konstantinos
Okorie, Michael
Stergiou, George S. and
Volpe, Massimo
Kreutz, Reinhold
Abraham, Gyorgy
Azizi,
Michel
Barna, Istvan
Barroso, Weimar Kunz Sebba
Brguljan,
Jana
Chapman, Neil
De Backer, Tine
Dorobantu, Maria and
Eckert, Siegfried
Gaciong, Zbigniew
Giannattasio, Cristina and
Glover, Mark
Gottsaeter, Anders
Grassos, Charalampos
Jarai,
Zoltan
Aguila, Fernando Jaen
Kahan, Thomas
Lopez-Sublet,
Marilucy
Lovic, Dragan
Lurbe, Empar
Makris, Thomas K. and
Mallamaci, Francesca
Manolis, Athanasios J.
Marketou, Maria and
Mazza, Alberto
Mediavilla, Juan Diego
Muiesan, Maria Lorenza and
Muxfeldt, Elizabeth Silaid
Nasr, Edgar
Papadakis, Ioannis and
Parounak, Zelveian
Obregon, Sebastian
Okorie, Michael and
Oliveras, Anna
Pontremoli, Roberto
Raev, Dimitar
Rajkumar,
Chakravarthi
Redon, Josep
Robles, Nicolas Roberto
Rump, Lars
Christian
Sarzani, Riccardo
Sierra, Cristina
Sirenko, Yuriy
and Stojanov, Vesna
Tikkanen, Ilkka
Vaclavik, Jan
Veglio,
Franco
Viigimaa, Margus
Webb, David
Zebekakis, Pantelis and
Zweiker, Robert
European Soc Hypertension Corona-V
Περιοδικό:
JOURNAL OF HYPERTENSION
Εκδότης:
Lippincott, Williams & Wilkins
Τόμος:
39
Αριθμός / τεύχος:
1
Σελίδες:
190-195
Λέξεις-κλειδιά:
Covid-19; blood pressure; hypertension routine care; renin-angiotensin
system inhibitors
Επίσημο URL (Εκδότης):
DOI:
10.1097/HJH.0000000000002703
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.